<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01742520</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-12-9389-IM-CTIL</org_study_id>
    <nct_id>NCT01742520</nct_id>
  </id_info>
  <brief_title>Neurodevelopmental Outcomes of Preterm Infants Treated for Pain Management With Repeated Doses of Sucrose 24%</brief_title>
  <official_title>Its an Interventional Study That Will Evaluate the Effect of Different Doses of Sucrose 24% on Neurodevelopmental Outcome of Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of sucrose 24% for pain prevention on
      preterm infants. Our hypothesis is that repeated doses of sucrose 24%, given prior to painful
      procedure,do not impair neurodevelopmental outcomes of preterm infants
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      preterm infants born at 27-33 weeks gestational age at Sheba Medical Center will be recruited
      for this study. Prior to invasive procedure infants will be treated with pacifier and
      swaddling as recommended by the American Academy of Pediatrics and Canadian Pediatric
      Society.

      Group 1.Will be treated with Sucrose 24% 0.1-0.5ml on the anterior pat of the tongue 1-3 min
      prior to invasive procedure.

      Group 2. Similar to group 1 but breast milk or formula will replace Sucrose.

      Number of invasive procedures/day will be documented

      General Movements by Prechtel will be used for developmental assessment at 2,4,6 weeks after
      birth and at 14-16 weeks corrected age

      Griffiths developmental scales (GMDS) will be used at 40 weeks, 14-16 weeks corrected age,
      and 3-6 month corrected age
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>neurodevelopmental outcomes</measure>
    <time_frame>at 6 month corrected age</time_frame>
    <description>Griffith mental developmental scaled (gross and fine motor, language, performance, social) and General movements by Prechtel</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>neurodevelopment</measure>
    <time_frame>at 15 weeks corrected age</time_frame>
    <description>Griffith mental developmental scaled (gross and fine motor, language, performance, social) and General movements by Prechtel</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Development</condition>
  <arm_group>
    <arm_group_label>Formula or Breast Milk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Breast milk or formula prior to every painful procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple doses of sucrose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants in this group will be treated with Sucrose 24% 0.5-1ml on the anterior pat of the tongue 1-3min prior to every invasive procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>multiple doses of sucrose</intervention_name>
    <description>unlimited number of doses par day- current status in our NICU</description>
    <arm_group_label>Multiple doses of sucrose</arm_group_label>
    <other_name>sucrose 24%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Formula or breast milk</intervention_name>
    <description>1-3 minutes prior to every painful procedure, breast milk or formula 0.5-1 ml will be given on the anterior part of the tongue</description>
    <arm_group_label>Formula or Breast Milk</arm_group_label>
    <other_name>sucrose 24%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preterm infants born at SMC

        Exclusion Criteria:

          -  need for intubation

          -  surgery

          -  need for sedation

          -  abnormal head ultrasound

          -  genetic abnormalities

          -  necrotizing enterocolitis

          -  other painful conditions other than routine blood exams
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>27 Weeks</minimum_age>
    <maximum_age>33 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iris Morag, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Iris Morag, MD</last_name>
    <phone>+972526479996</phone>
    <email>irismorag@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tzipi Strauss, MD</last_name>
    <phone>+97235302215</phone>
    <email>t.tzipi@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iris Morag, MD</last_name>
      <phone>+9725307170</phone>
      <email>irismorag@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Tzipora Strauss, MD</last_name>
      <phone>+9725302227</phone>
    </contact_backup>
    <investigator>
      <last_name>Iris Morag, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <results_reference>
    <citation>Johnston CC, Filion F, Snider L, Majnemer A, Limperopoulos C, Walker CD, Veilleux A, Pelausa E, Cake H, Stone S, Sherrard A, Boyer K. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics. 2002 Sep;110(3):523-8.</citation>
    <PMID>12205254</PMID>
  </results_reference>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2012</study_first_submitted>
  <study_first_submitted_qc>December 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2012</study_first_posted>
  <last_update_submitted>June 9, 2013</last_update_submitted>
  <last_update_submitted_qc>June 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Iris Morag</investigator_full_name>
    <investigator_title>Staff Neonatologist</investigator_title>
  </responsible_party>
  <keyword>Preterm infant</keyword>
  <keyword>pain</keyword>
  <keyword>neurodevelopment</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

